← All trials
NCT04331288
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 31, 2020
- Primary completion
- Aug 31, 2020
- Completion date
- Dec 31, 2020
- First posted
- Apr 2, 2020
- Last posted
- Apr 2, 2020
- Enrollment
- 10
- Arms / groups
- — / —
- Source
- AACT · ingestion pipeline
Sponsors
- Pop Test Oncology LLCLead sponsor
- Baylor UniversityCollaborator
- Department of DefenseCollaborator
- Department of Veteran AffairsCollaborator
- Pharmacotherapies for Alcohol and Substance Abuse ConsortiumCollaborator
- Baylor UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.